Show simple item record

dc.contributor.authorLal, S
dc.contributor.authorHayward, CS
dc.contributor.authorDe Pasquale, C
dc.contributor.authorKaye, D
dc.contributor.authorJavorsky, G
dc.contributor.authorBergin, P
dc.contributor.authorAtherton, JJ
dc.contributor.authorIlton, MK
dc.contributor.authorWeintraub, RG
dc.contributor.authorNair, P
dc.contributor.authorRudas, M
dc.contributor.authorDembo, L
dc.contributor.authorDoughty, RN
dc.contributor.authorKumarasinghe, G
dc.contributor.authorJuergens, C
dc.contributor.authorBannon, PG
dc.contributor.authorBart, NK
dc.contributor.authorChow, CK
dc.contributor.authorLattimore, J-D
dc.contributor.authorKritharides, L
dc.contributor.authorTotaro, R
dc.contributor.authorMacdonald, PS
dc.date.accessioned2020-12-16T23:40:13Z
dc.date.available2020-12-16T23:40:13Z
dc.date.issued2020-07-01
dc.identifierpii: S1443-9506(20)30133-5
dc.identifier.citationLal, S., Hayward, C. S., De Pasquale, C., Kaye, D., Javorsky, G., Bergin, P., Atherton, J. J., Ilton, M. K., Weintraub, R. G., Nair, P., Rudas, M., Dembo, L., Doughty, R. N., Kumarasinghe, G., Juergens, C., Bannon, P. G., Bart, N. K., Chow, C. K., Lattimore, J. -D. ,... Macdonald, P. S. (2020). COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ). HEART LUNG AND CIRCULATION, 29 (7), pp.E94-E98. https://doi.org/10.1016/j.hlc.2020.04.005.
dc.identifier.issn1443-9506
dc.identifier.urihttp://hdl.handle.net/11343/254455
dc.description.abstractUp to one-third of COVID-19 patients admitted to intensive care develop an acute cardiomyopathy, which may represent myocarditis or stress cardiomyopathy. Further, while mortality in older patients with COVID-19 appears related to multi-organ failure complicating acute respiratory distress syndrome (ARDS), the cause of death in younger patients may be related to acute heart failure. Cardiac involvement needs to be considered early on in critically ill COVID-19 patients, and even after the acute respiratory phase is passing. This Statement presents a screening algorithm to better identify COVID-19 patients at risk for severe heart failure and circulatory collapse, while balancing the need to protect health care workers and preserve personal protective equipment (PPE). The significance of serum troponin levels and the role of telemetry and targeted transthoracic echocardiography (TTE) in patient investigation and management are addressed, as are fundamental considerations in the management of acute heart failure in COVID-19 patients.
dc.languageEnglish
dc.publisherELSEVIER SCIENCE INC
dc.titleCOVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ)
dc.typeJournal Article
dc.identifier.doi10.1016/j.hlc.2020.04.005
melbourne.affiliation.departmentPaediatrics (RCH)
melbourne.source.titleHeart Lung and Circulation
melbourne.source.volume29
melbourne.source.issue7
melbourne.source.pagesE94-E98
melbourne.elementsid1449757
melbourne.openaccess.urlhttps://europepmc.org/articles/PMC7252099?pdf=render
melbourne.openaccess.statusPublished version
melbourne.contributor.authorWeintraub, Robert
dc.identifier.eissn1444-2892
melbourne.accessrightsAccess this item via the Open Access location


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record